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Vinculin is a highly conserved and abundant cytoskeletal pro-
tein involved in linking the actin cytoskeleton to the cell mem-
brane at sites of cellular adhesion. At these sites of adhesion,
vinculin plays a role in physiological processes such as cell
motility, migration, development, and wound healing. Loss of
normal vinculin function has been associated with cancer phe-
notypes, cardiovascular disease, and lethal errors in embryogen-
esis. The tail domain of vinculin (Vt) binds to acidic phospho-
lipids and has been proposed to play a role in vinculin activation
and focal adhesion turnover. To better characterize Vt-lipid
specificity, we conducted a series of lipid co-sedimentation
experiments and find that Vt shows specific association with
phosphatidylinositol 4,5-bisphosphate (PIP2), compared with
phosphatidylethanolamine (PE), phosphatidylcholine (PC),
phosphatidylserine (PS), or phosphatidylinositol (PI) in the con-
text of mixed lipid vesicles. The C terminus of Vt has been pro-
posed to be important for PIP2 association, as variousmutations
and deletions within the C-terminal reduce PIP2 association.
Lipid co-sedimentation and NMR analyses indicate that
removal of the hydrophobic hairpin does not alter Vt structure
or PIP2 association. However, more extensive deletions within
the C-terminal introduce Vt structural perturbations and
reduce PIP2 binding. Intriguingly, a significant increase in PIP2
bindingwasobserved formultipleVt variants that perturb inter-
actions between theN-terminal strap and helix bundle, suggest-
ing that a rearrangement of this N-terminal strap may be
required for PIP2 binding.
Vinculin is a highly conserved cytoskeletal protein which
localizes to points of cell adhesion and is involved in linking the
actin cytoskeleton to the cellmembrane (1). Sites of adhesion in
which vinculin is enriched include: focal adhesions (cell-extra-
cellular matrix), adherens junctions (cell-cell), costameres in
muscle cells, and intercalated discs in cardiac cells (1–3). At
these sites, vinculin is believed to play an important role in cell
adhesion processes involving regulation of the actin cytoskele-
ton. Moreover, vinculin has been linked to pathways that con-
trol cell growth, differentiation, motility, and survival (4–7).
Vinculin is also critical for proper development in model orga-
nisms (6, 8–10), and its loss in cells leads to increased motility,
invasiveness, and resistance to apoptosis (5, 11, 12). Decreased
vinculin expression and mutations have also been associated
with human cardiomyopathies (10, 13–15).
Vinculin is a 116-kDa cytoskeletal protein, and early studies
by electron microscopy and proteolytic cleavage identified a
globular head domain (Vh), a flexible neck, and a tail domain
(Vt)2 (16–18). The full-length structure of vinculin has been
solved by x-ray crystallography, and has been described as a
“bundle of bundles” (19, 20). Vh is composed of 7 helical bun-
dles organized into 3 tandem pairs of bundles (D1-D3) and one
unpaired bundle (D4) while Vt consists of a single helical bun-
dle. The head and tail domain are connected by a flexible pro-
line-rich region and interact to form a closed, autoinhibited
conformation with Vt held in a “pincer-like” state by Vh (Fig. 1)
(19). Vinculin binds a number of cytoskeletal and adhesion pro-
teins including: actin, talin, -actinin, -catenin, -catenin,
vinexin, ponsin, actin-related protein complex (Arp 2/3), vaso-
dilator-stimulated phosphoprotein (VASP), and paxillin. How-
ever, many of these interactions are at least partially masked in
the intact, unstimulated protein due to autoinhibitory interac-
tions between the head and tail domains (21–24).
Although two distinct models of vinculin activation have
been proposed, one common feature of these models is that
ligand binding either singly (25) or in concerted action (19) to
the vinculin head and/or tail domain, cause release of the head
from the tail domain to promote additional interactions. In fact,
the binding of several ligands to vinculin (i.e. F-actin, acidic
phospholipids, talin, and actinin) is modulated by head/tail
interactions. Hence, the binding of acidic phospholipids or
F-actin to the tail domain and the binding of talin or actinin to
the head domain have been proposed play a role in the separa-
tion of the head and tail domains, thus activating vinculin by
promoting interaction with additional ligands and/or covalent
modification (25, 26). If, acidic phospholipids do participate in
vinculin activation, binding of acidic phospholipids alone does
not appear sufficient to disrupt the high affinity head/tail inter-
action (19, 27). Rather, results obtained from recent fluores-
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binding of both talin and actin filaments to vinculin is required
for vinculin activation, suggesting an activation model involv-
ing combinatorial ligand binding to the head and tail domains
(28, 29). As the binding of phospholipids and F-actin are exclu-
sive, activation by acidic phospholipids would require a ligand
distinct from F-actin, such as talin. However, given that multi-
ple ligands have been proposed to play a role in vinculin activa-
tion, different combinations of ligands may allow vinculin acti-
vation to be spatially and temporal regulated (30). In addition to
their putative role in vinculin activation, acidic phospholipids
have also been proposed to facilitate PKC-phosphorylation,
prevent actin binding, promotemembrane association and reg-
ulate focal adhesion turnover (19, 26, 31, 32). Clearly, a better
understanding of how acidic phospholipids interact with vin-
culin will aid in establishing its role in modulating vinculin
function.
Although vinculin has been shown to bind acidic phospho-
lipids, including phosphatidylserine (PS), phosphatidylinositol
(PI), and phosphatidylinositol 4,5-bisphosphate (PIP2), the rel-
ative affinity for various acidic phospholipids under conditions
thatmimic physiological ionic strength andmembrane compo-
sition has not been reported.
Phosphoinositides, including PIP2, have been shown to be
regulated both spatially and temporally at sites of actin assem-
bly and cytoskeletal remodeling (33–36). Although a number of
structurally conserved phosphoinositides and PIP2 binding
motifs have been identified (37–39), none have been found
within the vinculin tail domain. The structure of Vt has been
solved by x-ray crystallography, and found to be comprised of a
5-helix bundle motif, similar to that observed in the intact pro-
tein (19, 20, 26). Based on this structure, three regions of Vt
were proposed to play a role in bind-
ing acidic phospholipids; a C-termi-
nal extension containing a “hydro-
phobic hairpin”, a “basic collar”
consisting of lysine and arginine res-
idues from helix 1, helix 5, and the
C-terminal extension which sur-
rounding the hydrophobic hairpin,
and a “basic ladder” of exposed basic
residues along the length of helix 3
(26). A series of vinculin mutagene-
sis studies have been conducted to
pinpoint the site of lipid binding
within Vt. However, the data are
somewhat difficult to interpret, as
the number, location, and effect-
iveness of the mutations vary.
Although some phospholipid de-
fective variants have been charac-
terized to determine whether the
mutation(s) affect other ligand
binding interactions (i.e. Vh, actin),
the impact of the mutation(s) on Vt
structure and stability are largely
unknown. Thus, the exact site and
mode of phospholipid binding is
still unclear. Further complicating
the field, Vt constructs of varying lengths have been used in
separate studies. As the vinculin tail domain is connected to the
remainder of vinculin by a flexible loop, various Vt constructs
containing different N termini have been constructed. Pub-
lished studies have utilized constructs containing residues 811–
1066, 858–1066, 879–1066, 881–1066, and 884–1066 (26, 28,
40–42), with constructs containing residues 879–1066 and
884–1066, extensively employed for characterizing Vt-ligand
interactions. For clarity, we will refer to Vt-(879–1066), the
construct used to determine the crystal structure of vinculin tail
domain as wild-type Vt, and the construct containing 884–
1066, as VtN. To better characterize phospholipid binding
interactions with the vinculin tail domain (Vt), we have exam-
ined the relative ability of various acidic phospholipids to asso-
ciate with the vinculin tail domain using lipid co-sedimentation
assays, and performed biophysical characterization and lipid
binding studies on various Vt mutations that alter interactions
with the N-terminal strap or within the C terminus.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—Vinculin tail (Vt) con-
structs containing residues 879–1066 (generously provided by
Dr. Robert Liddington) and 884–1066 of chicken vinculin in a
pET15b vector (Novagen), have been described previously (26,
27). Vtmutagenesis was performed using theQuikChange site-
directed mutagenesis kit (Stratagene) and verified by DNA
sequencing. Vectors were transformed into Escherichia coli
strain BL21(DE3), and cells were grown at 37 °C to an optical
density of 0.6 (600 nm). Vt expression was initiated by addition
of 0.25 mM isopropyl -D-1-thiogalactopyranoside. Cells were
grown for an additional 5 h and harvested by centrifugation. Vt
FIGURE 1. A, a ribbon diagram illustrating the structure of full-length vinculin (PDB ID 1ST6). In the closed,
autoinhibited conformation, the clamp-like head domain (Vh, D1 (red), D2 (green), D3 (magenta), and D4 (cyan))
forms a tight interaction with the tail domain (Vt, (multi-color)). Current models of vinculin activation and
function require the release of the head/tail interaction to allow ligand binding. B, a ribbon diagram illustrating
the isolated tail domain of vinculin (PDB ID 1ST6). The N-terminal strap and C-terminal extension are high-
lighted (green and yellow, respectively). The hydrophobic hairpin at the extreme C terminus is shown in red.
Select helices are labeled (e.g. H-1), and for clarity, the helices are colored identically in parts A and B. A more
detailed illustration, highlighting specific interactions between the N-terminal strap and C-terminal extension,
is shown in Fig. 7.
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was expressed at high level and purified from both the soluble
and insoluble fraction. Cell pellets were resuspended in a lysis
buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM
imidizole, 0.1% -mercaptoethanol (BME), and lysed by soni-
cation. Vt, expressed in the soluble fraction, was separated from
the particulate fraction by centrifugation for 1 h at 25,000  g.
The fraction containing soluble Vt, was purified by affinity sep-
aration using Ni-NTA-agarose beads (Qiagen). Vt was washed
and eluted from the beads using lysis buffer containing 60 mM
and 500 mM imidizole, respectively, and then dialyzed into
thrombin cleavage buffer (20 mM Tris, pH 7.5, 500 mM NaCl,
2.5 mM CaCl2, 0.1% BME). The histidine (His)-tag was cleaved
by thrombin (1 unit per 5 mg protein, Sigma) overnight at
37 °C. Cation-exchange chromatography (HiPrep 16/10 SP XL
column from GE Healthcare Life Sciences) was used to further
purify Vt, using a 0.05–1 MNaCl gradient in a buffer containing
20 mM Tris (pH 7.5), 2.5 mM EDTA, and 0.1% BME.
Vt was also purified from the insoluble fraction by resus-
pending cell pellets in 6 M guanidinium chloride (GdmCl) prior
to sonication. A protocol similar to that used for soluble Vt was
employed, except that purification from Ni-NTA-agarose
beads was carried out under denaturing conditions. Following
elution, GdmCl was removed, and Vt refolded by dialysis in a
buffer containing 20 mM Tris, pH 7.5, 500 mM NaCl, and 0.1%
BME. The His-tag was removed with thrombin and Vt further
purified by gel filtration exchange chromatography, using
methods described for the natively folded Vt protein. Proper
refolding was verified by comparison of 1H-15N HSQC spectra
acquired on refolded and natively folded 15N-enriched Vt.
LipidCo-sedimentation—Lipid binding toVtwas assessed by
co-sedimentation with small, unilamellar vesicles (SUV). The
ability of Vt to bind PI and PS was analyzed using lipid vesicles
containing 60% PE, 40% PC by weight, with either PI or PS
replacing PE at the concentration indicated. PIP2 binding to Vt
was characterized using vesicles containing 60% PE, 20% PC,
and either 20% PS byweight or PIP2 replacing PS at the concen-
tration indicated. For example, experiments testing the role of
10% PIP2, employed vesicles composed of 60% PC, 20% PE, 10%
PS, and 10% PIP2. Vesicles were produced by combining the
appropriate lipids suspended in chloroform, to produce a sam-
ple containing 250g of total lipid. Themixturewas dried using
a SpeedVac and then resuspended in 90 l of buffer containing
40 mM 4-HEPES, 150 mM NaCl, and 2 mM dithiothreitol, pH
7.4. Resuspension and generation of the SUVs were accom-
plished by brief sonication with a probe tip sonicator. 10 l of
100Mprotein (in an identical buffer) was added to each vesicle
sample, producing a final volume of 100l and protein concen-
tration of 10 M. The total lipid in each sample is 250 g or
3.0–3.2 mM. Samples were nutated at 4 °C for 1 h, then cen-
trifuged at 100,000  g for 1 h. The supernatant was removed,
and the pellet resuspended in buffer containing 0.1% SDS, 25
mM glycine, and 25 mM Tris, pH 8.3. Supernatant and pellet
samples were analyzed by SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE). Gels were stained with Coomassie Blue,
scanned, and protein levels quantified using Image J software
(43).
NMR Samples and Spectroscopy—Bacterial-expressed 15N-
labeled Vt protein was produced for nuclear magnetic reso-
nance spectroscopy (NMR) studies by growth in M9 minimal
media containing 1g/liter [15N]NH4Cl (Spectra Stable Iso-
topes). NMR samples were exchanged intoNMRbuffer (10mM
potassium phosphate, 50 mM NaCl, 2 mM dithiothreitol, 0.1%
NaN3, and 10% D2O at the indicated pH) using an Amicon
Ultra centrifugal filter device (10000-Da molecular weight cut-
off, Millipore). 1H-15N Heteronuclear Single Quantum Coher-
ence (HSQC) spectra were collected on a Varian INOVA 700
MHz spectrometer at 37 °C (44). Backbone chemical shift
assignments of Vt under these conditions have been reported
previously (45), and have been deposited in the BiologicalMag-
netic Resonance Data Bank (accession number 15653). NMR
data processing and analysis was performed using NMRPipe
(46) and NMRView (47).
Circular Dichroism—Circular dichroism (CD) spectra were
collected at both near-ultraviolet (350–250 nm) and far-ultra-
violet (260–190 nm) spectral regions. All spectrawere acquired
at 25 °C in a buffer contained 10 mM potassium phosphate, 50
mM Na2SO4, and 1 mM dithiothreitol, pH 7.5 using an Applied
Photophysics Pistar-180 spectrometer. Protein concentrations
were 0.45 mM and 5 M for near-UV and far-UV CD data col-
lection, respectively.
RESULTS
The Vinculin Tail Domain Shows Specificity for PIP2-con-
taining Vesicles—Although the tail domain of vinculin has been
reported to bind acidic phospholipids and PIP2, both the con-
structs used and themethods used to assess acidic phospholipid
binding have varied significantly, making comparison of sepa-
rate reports on lipid binding difficult (19, 26, 27, 31, 48, 49). To
clarify the affinity and specificity of Vt for PIP2, we performed
co-sedimentation experiments with mixed PE, PC, and PS ves-
icles, examining the effect of increasing PIP2 concentration.
Although Vt-(884–1066) has previously been shown to bind to
pure PS and PI vesicles at physiological ionic strength (27), we
found that under physiological lipid and salt concentrations, no
significant binding of Vt-(879–1066) to PS or PI in mixed lipid
vesicles was observed. In the absence of PIP2, little co-sedimen-
tation of Vt with mixed lipid vesicles containing 60% PC, 20%
PE, and 20% PS vesicles was observed in 150 mM NaCl (Fig. 2).
Upon the addition of PIP2, however, a clear concentration-de-
pendent co-sedimentation was observed, indicating that Vt
specifically recognizes PIP2.
The vinculin tail domain has also been reported to interact
with pure PI vesicles (using a 30-kDa V8 proteolytic fragment)
(27) and pure PS vesicles (using Vt-(879–1066)) (26). To ascer-
tain the relative affinity of Vt for PI, PS, and PIP2, Vt association
was observed in mixed lipid vesicles containing each of these
lipids. As shown in Fig. 3, Vt does not bind PI or PS significantly
in the context of mixed lipid vesicles, and demonstrated a
marked preference for PIP2 over either PI or PS.
Vt Demonstrates Loss of Tertiary in Lipid Micelles—As
shown in Figs. 2 and 3, the vinculin tail domain shows enhanced
association with PIP2 in lipid co-sedimentation relative to PS
and PI. In an effort to determine the site(s) of interaction
between Vt with PIP2, we employed CD and solution NMR
spectroscopy. Studies of phospholipid interactions were initi-
ated using micelles as opposed to larger vesicles. However,
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introduction of dodecylphosphocholine (DPC) at concentra-
tions that promote micelle formation causes a collapse in Vt
structure, as determined by both near-UV (ultraviolet) CD and
1H-15N heteronuclear two-dimensional NMR.
Near-UV CD is sensitive to the tertiary packing of aromatic
residues and therefore the tertiary structure of proteins,
whereas far-UVCD is sensitive to the conformation of the pep-
tide backbone and therefore the secondary structure of pro-
teins. The far-UV CD of Vt exhibits only minor changes in the
presence of 100 mM DPC indicating there is no significant
change in the secondary structure whereas the near-UV CD
spectra exhibits a significant loss of signal, indicating a loss of
tertiary structure (Fig. 4A).
The 1H-15N HSQC NMR spectra detect signals for protons
attached to 15N nuclei. The backbone NH of each amino acid
(with the exception of proline) providing a residue specific
probe sensitive to changes in its electrochemical environment.
1H-15N HSQC spectral dispersion arises from the unique envi-
ronment of each distinct NH pair. Loss of a distinct, folded
structure results in convergence of resonances toward random
coil chemical shifts (centered at8.3 ppm). The significant loss
of spectral dispersion observed forVt in the presence of 100mM
DPC (Fig. 4B) is indicative of a significant loss in tertiary struc-
ture, in agreement with the near-UV CD. The residual disper-
sion observed by NMR, also agrees with the persistence of hel-
ices as detected by far-UV CD.
AlthoughVt has been proposed to undergo a conformational
change upon association with acidic phospholipids (26), DPC
micelles may act as a detergent causing unfolding of Vt. As Vt
does not bind to PC containing vesicles, the interaction with
DPC micelles may be nonspecific. Adding to this possibility, a
similar collapse inNMRchemical shift dispersionwas observed
in 1H-15N HSQC spectra of Vt in the presence of 1-palmitoyl-
2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] (LPPG)
(data not shown).
Attempts to map the PIP2 interaction site by NMR using
the PIP2 headgroup, D-myo-inositol-1,4,5-triphosphate or a
short chain (C8) derivative of PIP2 were also unsuccessful
(data not shown), as a clear, specific binding site was not
observed. These results indicate that the head group alone
does not have sufficient affinity for Vt to either bind specif-
ically or promote a conformational change in Vt, necessary
for high affinity binding.
Certain C-terminal Residues Stabilize the Tertiary Fold of Vt—
A C-terminal deletion variant of Vt reported to be deficient in
lipid binding has been utilized in multiple studies (19, 26, 31,
32). This mutant, VtC, lacks 15 C-terminal amino acids
(1052–1066). The deletion of this fragment has been reported
to decrease PIP2 binding but does not significantly affect inter-
action with either actin or the head domain of vinculin (26, 32).
However, VtC demonstrates an increased susceptibility to
protease degradation (26, 32) as well as alterations in one
dimensional 1H NMR spectra, indicating loss of structure (32).
As residues in the C terminus of Vt form tertiary interactions
with other residues in the tail domain, the loss of these interac-
tions upon deletion could alter the structure and stability of Vt.
In particular, the deletion results in removal of tryptophan 1058
(Trp-1058), which packs against tryptophan 912 (Trp-912) in
the loop between helix 1 and 2. Interestingly, both tryptophan
residues are conserved in all vinculins aswell as-catenin, a cell
adhesion protein with high homology to vinculin (32, 50).
Along with Trp-1058, VtC removes leucine 1056 (Leu-1056),
which also packs into the base of the hydrophobic core. Loss of
these packing interactions could alter Vt structure resulting in
destabilization. In full-length vinculin, there is also an interac-
tion between the C terminus and the N-terminal strap of Vt,
withAsp-882 of theN-terminal strapmaking polar interactions
FIGURE 2. Lipid binding properties of wild-type Vt was examined by co-
sedimentation with lipid vesicles containing 60% PE, 20% PC, and either
20% PS by weight or PIP2 at concentrations that replace PS. Soluble (S)
and pellet (P) fractions were analyzed by SDS-polyacrylamide gel electro-
phoresis (stained with Coomassie Blue), with a representative gel shown. Gels
were scanned and the amount of protein in each fraction quantified using
ImageJ software. Wild-type Vt shows minimal binding to vesicles contain-
ing 60% PE, 20% PC, and 20% PS (displayed as 0% PIP2). In the presence of
PIP2, a dose-dependent increase in lipid association was observed, sug-
gesting specificity for PIP2 association. Error bars represent a S.D. of more
than 3 separate measurements.
FIGURE 3. To compare the relative affinity of Vt for PS, PI, and PIP2, the
ability of Vt to co-sediment with mixed lipid vesicles containing PE, PC,
and either PS or PI was assessed. These results indicate that Vt specifically
recognizes PIP2 relative to PS and PI, as concentration-dependent binding to
PIP2 is observed, with minimal binding of PS and PI observed at concentra-
tions up to 15%. Error bars represent the S.D. of 3 separate measurements.
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with C-terminal residues, Lys-1061 and Tyr-1065 (19). To bet-
ter understand the role of theVtC terminus in lipid binding, we
conducted NMR and CD analyses of the VtC variant. As
reported previously, we found VtC to be significantly more
susceptible to proteolytic cleavage than wild-type Vt (26, 32).
Moreover, two-dimensional 1H-15N (NMR) spectra of 15N-en-
riched wild-type and VtC, indicate that the C-terminal dele-
tion results in significant loss of tertiary structure. As shown in
Fig. 5A, the 1H-15N HSQC spectra of wild-type Vt displays
spectral dispersion consistent with that of a well folded -heli-
cal protein. In contrast, the 1H-15N spectrum of VtC exhibits
increased spectral overlap, resulting froma collapse in chemical
shift dispersion and an increase in the number of resonances
with random coil chemical shifts (Fig. 5A). Moreover, the
majority of resonances exhibit chemical shift changes. These
NMR data support a loss of structural stability upon deletion of
the C-terminal residues.
While the near UV CD (350–250 nm) of VtC could not be
directly compared with wild-type Vt due to the removal two of
the three tryptophan residues in the protein (Trp residues dom-
inate absorption in the near UV CD spectrum), far UV CD
(260–190 nm) which is sensitive to the secondary structure of
proteins, suggests that the helical content of wild-type Vt and
VtC are nearly identical (Fig. 5B). Together, this data suggest
that while the secondary structure of VtC is largely unaltered
relative to wild-type Vt, its tertiary conformation and stability
may be significantly altered.
Structural changes in VtC have been attributed, at least in
part, to loss of Trp-1058 (32). However, other residues associ-
atedwith theC-terminal deletionmay be involved in lipid bind-
ing. The “hydrophobic hairpin” (TPWYQ at the extreme C ter-
minus) has been postulated to be important for vinculin
insertion into the membrane, and
mutagenesis studies indicate that
Arg-1057, Arg-1060, and Lys-1061
(part of the “basic collar”) may be
involved in binding acidic lipid head
groups (26, 31). To elucidate the
role of these residues in Vt struc-
tural integrity, we generated two
new C-terminal deletion mutants,
VtC5 and VtC7. VtC5 is a dele-
tion which removes 5 amino acids
from Vt that make up the hydro-
phobic hairpin (TPWYQ), whereas
in VtC7, two additional amino
acids are deleted, Arg-1060 and Lys-
1061, which are part of the basic col-
lar. As shown in Fig. 6A, the 1H-15N
HSQC spectra of VtC5 is nearly
identical to that of wild-type Vt,
suggesting that removal of the
hydrophobic hairpin has a minimal
effect on the structure of the pro-
tein. In contrast, the 1H-15N HSQC
spectra of VtC7 exhibits signifi-
cant spectral changes, showing
some similarity to that observed in
VtC (chemical shift changes, increase in overlap, increase in
resonances with random coil chemical shifts), although the
spectra changes observed for VtC7 are not as extensive as
those observed forVtC (Figs. 5A and 6B). Thus, ourNMRdata
indicate that Arg-1060 and Lys-1061 may play a role in main-
taining the tertiary fold of Vt. These observations are consistent
with observations that these residues form tertiary contacts
with other residues in the crystal structure of full-length vincu-
lin. Located in the C terminus, Arg-1060 and Lys-1061 make
contacts with residues in the N terminus and in the helix 1–2
loop, including polar contacts with Asp-882 (N terminus) and
Lys-911 (helix 1–2 loop). Although the effect of deleting these
residuesmay differ significantly from that of pointmutations, it
remains possible that mutation of these residues could affect
the structure or stability of Vt.
The Role of the N-terminal Strap in PIP2 Binding—A signifi-
cant number of mutations have been made in Vt to assess their
affect on lipid binding. In addition to theVtCdeletionmutant,
a variety of basic residues have beenmutated, targeted predom-
inately to residues in the “basic collar” and “basic ladder” (19,
31, 32). To elucidate lipid binding determinants in Vt, we char-
acterized a series of mutants in both Vt-(879–1066) as well as a
shorter construct of Vt containing residues 884–1066, referred
to here as VtN (27).
The N terminus of Vt contains a “strap”, residues 879–892,
which is found in an extended conformation and packs against
the interface of helices 1 and 2 in the crystal structure of full-
length vinculin (19). The N-terminal strap is found in multiple
conformations in the crystal structure of Vt, suggesting confor-
mational flexibility (26). In the full-length crystal structure, the
N-terminal strap forms contacts with the Vt helix bundle via
contacts with both phenylalanine 885 (Phe-885) and aspartic
FIGURE 4. CD and NMR analysis of Vt in the presence of DPC micelles. Comparison of far (A) and near (B) UV
CD spectra of Vt in the presence and absence of 100 mM DPC. While far UV CD spectra show similar spectral
profiles, significant alterations are observed in the near UV CD spectra. Results from these analyses indicate that
DPC micelles cause a loss in Vt tertiary structure but maintain helical secondary structure. The data are further
supported by NMR studies. 1H-15N HSQC NMR spectra were collected on 0.15 mM Vt at pH 5.5, both alone and
in the presence of 100 mM DPC (C). The loss of spectral dispersion and the increase in resonances with chemical
shifts close to the random coil values (8.3 ppm), suggest a loss in Vt tertiary structure upon association with
DPC micelles. As vinculin does not appear to specifically bind PC, interactions with DPC micelles are likely to be
nonspecific. In addition, similar structural perturbations were observed with all lipid micelles tested (i.e. LPPG
and short-chain PIP2), suggesting that lipid micelles may act as a detergent, unfolding Vt.
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acid 882 (Asp-882). The side chain of Phe-885 packs against the
side chain of histidine 906 (His-906) in helix 1, while Asp-882
makes a number of polar contacts with other residues in Vt,
including Ser-914 (helix 1–2 loop), Lys-924 (helix 2), and Lys-
1061 and Tyr-1065 in the C terminus (Fig. 7A). Thus, removal
of 5 amino acids from theN terminus of Vt (i.e, VtN) results in
the loss of Asp-882, andmultiple interactions betweenAsp-882
and theVt helix bundle andC terminus. Comparison of 1H-15N
HSQC spectra of 15N-enriched wild-type Vt and VtN, show
differences in NH chemical shifts associated predominately
with residues in the N-terminal strap, the helix 1–2 interface,
and the C terminus, consistent with the loss of contacts
between these regions and the strap, due to the deletion of 5
N-terminal residues. The lack of chemical shift changes for
most residues in the helix core, suggest that the helix bundle
remains intact.Molecular dynamics (MD) simulations of VtN
were also conducted using the x-ray crystal structure of Vt
(taken from PDB ID 1ST6) as a starting point and removing the
5 N-terminal amino acids. Consistent with our NMR data,
results from theMDsimulations of VtNshow an intact helical
bundle but flexible N and C termini (data not shown). Hence,
our computational andNMRdata suggest that deletion of theN
terminus of Vt perturbs interactions between the strap, helix
FIGURE 5. NMR and CD analysis of the lipid-defective C-terminal deletion
mutant, VtC. Compared with wild-type Vt, the 1H-15N 2D NMR spectra of
VtC (A) shows increased overlap resulting from a collapse in chemical shift
dispersion and an increase of resonances with random coil chemical shifts
(8.3 ppm), consistent with a loss of structural stability due to the C-terminal
deletion (VtC in red overlaid on wild-type Vt in black). In contrast, far UV CD
spectra of wild-type Vt and VtC are similar (B), suggesting retention in the
overall helical content.
FIGURE 6. To assess the role the hydrophobic hairpin and C-terminal
basic collar residues on Vt structure, two deletion mutants, VtC5 and
VtC7, were created. VtC5 removes only the hydrophobic hairpin (the
final five C-terminal residues), while VtC7 removes an additional two resi-
dues that are part of the basic collar (R1060 and K1061). As observed in A, the
1H-15N HSQC spectra of VtC5 is nearly identical to that of wild-type Vt, indi-
cating that deletion of the hydrophobic hairpin does not alter the structure of
Vt. In contrast, the 1H-15N HSQC spectrum of VtC7 (B) shows large scale
spectral changes compared with wild-type Vt, with both intensity and chem-
ical shift changes observed for the majority of NH resonances. Moreover, sev-
eral of the NH resonances show higher intensity, random coil chemical
shifts, suggesting some loss of structure. However, the spectral changes
observed for VtC7 are not as extensive as those observed for VtC (Fig.
5). These data indicate that deletion of R1060 and K1061 in the C terminus
of Vt causes a loss in structure, suggesting that these residues play a role in
the tertiary stability of Vt.
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1–2 interface, and C terminus, but does not cause a large scale
structural changes in the 5-helix bundle fold. This is consistent
with previous observations, showing that VtN can interact
with acidic phospholipids and Vh, and can bind/bundle F-actin
(21, 27, 29, 30, 51).
Intriguingly, we found the lipid binding capacity of VtN to
be significantly different from wild-type Vt. While the lipid
binding specificity of VtNwas nearly identical to Vt (minimal
binding to PS and PI, data not shown), the affinity for PIP2 was
considerably higher (Fig. 7B). As one of the points of interaction
between the N-terminal strap and the helical bundle (Asp-882)
has been removed in VtN, we hypothesized that the enhance-
ment observed in PIP2 binding may be due to release or partial
release of strap. To test this hypothesis, we conducted lipid
co-sedimentation assays on two mutants, Vt D882A and Vt
H906A. Mutation of either of these residues should disrupt
interactions with the N-terminal strap. In particular, mutation
of His-906 to alanine should disrupt packing with Phe-885
while the aspartic acid to alanine mutation at 882 should dis-
rupt polar contacts Ser-914, Lys-924, Lys-1061, and Tyr-1065.
Results shown in Fig. 7B, indicate that both mutants signifi-
cantly increase the co-sedimentation ofVtwith PIP2 containing
lipids, consistent with our hypothesis that release of the N-ter-
minal strap increases PIP2 binding. As the base lipid vesicle
composition in the 0% PIP2 samples contain 20% PS, these
results indicate that the Vt variants (VtN, VtD882, and
VtH906A) retain specificity for PIP2 over PS.
As previously mentioned, we found that changes in the
1H-15N HSQC spectra of VtC are indicative of loss in struc-
ture relative toVt, whileVtC5,which removes only the hydro-
phobic hairpin at the C terminus of Vt, shows similar NMR
spectra towild-typeVt, indicating a similar fold. AsVtC5does
not appear to perturb the tertiary fold of Vt and is postulated to
play a role in membrane insertion, we conducted lipid co-sed-
imentation experiments with VtC5. As shown in Fig. 7B, we
find that VtC5 exhibits similar binding to PIP2 containing
vesicles, indicating that the hydrophobic hairpin is not critical
for lipid binding.
DISCUSSION
The regulation of the actin cytoskeleton, its connections to
the cell membrane, and the linkage to neighboring cells or extra
cellular matrix, play an integral part in many physiological and
pathological processes. Cell processes includingmigration, dif-
ferentiation, proliferation, and survival, along with larger scale
processes such as tissue organization, wound healing, and
tumorigenesis are regulated in part by dynamic regulation of
cell adhesions and the actin cytoskeleton (52–55). Motility
changes required formany of theses processes involve dynamic
creation, stabilization, and turnover of sites of adhesion (56,
57), with vinculin playing an important role (5, 31, 32, 40, 58).
The activation and function of vinculin has been shown to be
spatially and temporally regulated in cells, and vinculin is
believed to play an integral role in strengthening of adhesions
(59, 60). Intriguingly, interactions with lipids play a role in the
regulation of adhesion site turnover (31, 32). The lipid binding
function of vinculin is localized to the tail domain (Vt), which
has previously been shown to associate with acidic phospholip-
ids, including PS, PI, and PIP2 (22, 27). Of these, PIP2 is of
particular interest, as it is known to be an important regulator of
the actin cytoskeleton (39).Many of the reports of Vt lipid bind-
FIGURE 7. A, structure of Vt (from 1ST6), highlighting the interactions of the N-ter-
minal strap of Vt with the helix 1–2 interface and the C terminus. The N-terminal
strap of Vt is depicted in green, while the C terminus is shown in yellow (with the
hydrophobic hairpin shown in red). The N-terminal strap of Vt packs in an
extended conformation with the helix 1–2 interface. Two residues within the
strap, F885 and D882, form multiple interactions within Vt that are likely to stabi-
lize the extended conformation of the strap. F885 of the N-terminal strap packs
against H906 of helix 1, while D882 forms multiple polar interactions with S914
(helix 1–2 loop), K924 (helix 2), and K1061 and Y1065 in the C terminus of Vt.
B, while wild-type Vt exhibits a PIP2-dependent association with lipid vesicles, a
number of Vt mutants show a marked increase in PIP2 affinity relative to wild-type
Vt. Of these, VtN, Vt D882A, and Vt H906A are likely to perturb interactions
between the Vt-helix bundle and the strap, thereby increasing conformational
mobility of the N-terminal strap. The increase in PIP2 binding observed with these
mutants is consistent with the hypothesis that a conformational change or
removal of the N-terminal strap of Vt facilitates higher affinity PIP2 association.
Error bars represent the S.D. of 3 separate measurements.
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ing were in the context of pure lipid vesicles. Hence, we were
interested in assessing phospholipid binding using mixed lipid
vesicles that better mimic cellular membranes. We found that
Vt does not bind significantly to vesicles containing PE, PC, and
PS, while demonstrating a significant concentration dependent
binding to PIP2 containing vesicles (Fig. 2). Although Vt has
been shown to bind pure PI and PS vesicles, we observed only
minimal co-sedimentation withmixed lipid vesicles containing
PI or PS (Fig. 3). Local concentrations of PIP2 are controlled by
both synthesis and sequestration, and regulated by signaling
pathways known to affect the actin cytoskeleton (38). The selec-
tive affinity of vinculin for PIP2 suggests that this interaction
may provide an important link in the regulation of actin
cytoskeletal dynamics.
Our lipid co-sedimentation assays indicate that Vt exhib-
its specificity for binding to PIP2, but does not specifically
associate with vesicles containing mixtures of PE, PC, and
PS. It is of interest to note that while vinculin does not appear
to specifically bind PC, at the 100 mM concentration used
for NMR we see interactions with dodecylphosphocholine
(DPC) micelles. In fact our CD and NMR data suggest that,
while secondary structure may be retained, there is a loss of
tertiary structure and lipid specificity upon association with
micelles (Fig. 4). These observations suggest that lipid
micelles may function as a detergent and unfold Vt. There-
fore, micelles may not mimic physiological lipid interactions
and caution should be used in interpreting data on Vt in
micelles.
How PIP2 interacts with Vt to modulate vinculin function
remains unclear. Vinculin does not contain known PIP2 bind-
ing motifs (37), and mutation and deletions reported to block
lipid binding have not identified a clear site of binding (19, 22,
26, 27, 31, 32). Supporting the observations of Saunders et al.
(32), our data support a loss in structural stability associated
with the C-terminal deletion mutant VtC (Fig. 5). Hence, loss
of lipid bindingmay result from an altered tertiary structure. In
contrast, removal of the hydrophobic hairpin does not signifi-
cantly alter PIP2 association and does not appear to alter Vt
structure. Thus, although the hydrophobic hairpin has previ-
ously proposed to be important for insertion of vinculin into
membranes (26), our results indicate that removal of the hydro-
phobic hairpin (TPWYQ) is not critical for lipid insertion.
Removal of an additional two amino acids from the C termi-
nus, VtC7, causes spectral perturbations that may be indic-
ative of a structural change, albeit not as extensive as those
observed for VtC (Fig. 6). These results indicate that per-
turbations of contacts between the basic collar residues,
Arg-1060 and Lys-1061, with the helix 1–2 loop and the
N-terminal strap, may alter Vt structure, which should be
noted when interpreting the lipid binding data of Vt variants
containing mutations at these positions.
Intriguingly, analysis of lipid binding data on multiple Vt
mutants (VtN, D882A, and H906A), indicates that perturba-
tion of interactions with the N-terminal strap of Vt enhances
PIP2 association (Fig. 7). It is possible that the release of this
strapmay expose a surface important for lipid binding, allowing
for the formation of a lipid binding surface not present in the
closed conformation, or more readily allow a conformational
change required for lipid binding. It is intriguing to speculate
that residues in the basic collar (Lys-911 and Lys-924) become
more accessible for interaction with PIP2 upon release of the
N-terminal strap, as these residues have been proposed to
be important for PIP2 association (19, 32). Additionally, as the
N-terminal strap makes interactions with the C terminus, it is
possible that rearrangement of the strap could cause perturba-
tions or increased conformational mobility in the C terminus,
which could facilitate PIP2 interactions. It has also been
reported that a rearrangement in the N-terminal strap of Vt
may be required for F-actin bundling (61), and that PIP2 bind-
ing inhibits interactions of vinculin with F-actin (30, 48). Rear-
rangement of the N-terminal strap of Vt may be a common
requirement for the binding of either PIP2 or F-actin, with both
ligands sharing a mutually exclusive, overlapping site of inter-
action. This would be consistent with the hypothesis that PIP2
binding may displace vinculin from F-actin, allowing focal
adhesion turnover as has been proposed (31, 32).
In summary, results from our studies indicate that Vt shows
specificity for PIP2 in mixed lipid vesicles that better mimic
membrane lipid composition than those used in earlier studies.
In particular, Vt binds to lipid vesicles in a PIP2-dependent
manner, with minimal binding in the absence of PIP2. In con-
trast, no significant binding was observed with lipid vesicles
containing up to 15% PS or PI. However, in the presence of lipid
micelles, Vt loses tertiary structure while retaining secondary
structure. Additionally, while Vt does not specifically interact
with PC in larger lipid vesicles, it does interact with DPC in
micelles, suggesting lipid specificity may be lost in the context
of lipid micelles. Thus, Vt-micelle interactions may not ade-
quately reflect Vt-membrane interactions. Furthermore, our
CD and NMR data indicate that the mutant, VtC, reported to
be deficient in lipid binding, appears to have significantly
altered tertiary structure, likely due to deletion of packed
hydrophobic residues (Leu-1056 and Trp-1058). A loss of ter-
tiary structure is also observed for the shorter C-terminal dele-
tion mutant, VtC7, suggesting that the basic collar residues
Arg-1060 and Lys-1061, may be important for the structural
integrity of Vt. In contrast, removal of the hydrophobic hairpin
(i.e. VtC5) shows no evidence of structural perturbation and
retains PIP2 binding, suggesting the hydrophobic hairpin is not
critical for lipid interactions. Conversely, mutations likely to
alter the interaction of the N-terminal strap of Vt (VtN,
VtD882, and VtH906A) exhibit significant increases in PIP2
binding and retain PIP2 specificity, suggesting that release of
the N terminus strap promotes PIP2 binding. Thus, PIP2 bind-
ing may require a conformational change in the N-terminal
strap to promote a higher affinity PIP2 association.
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